BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc.: The essential types of services provided by the vendors and players functional within the global bioinformatics services market include data analysis, gene expression, sequencing, database management, and discovery, among others.

The global veterinary stereotactic radiosurgery system market is expected to witness moderate growth during the forecast period between 2021 and 2031.

Amryt today announces that its unaudited financial results for the second quarter 2022 will be released on Thursday, August 4, 2022 at 0700 ET/1200 BST.

The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its second quarter 2022 financial results on Thursday, August 4, 2022, after the market close.

IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced it will report financial results for the second quarter 2022 before market open on Wednesday, August 10, 2022.

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on advancing innovative gamma-delta T cell therapies utilizing its DeltEx platform, today announced the issuance of an additional European patent covering the composition of matter for IN8bio’s Drug Resistant Immunotherapy (DRI) platform.

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the New England Journal of Medicine (NEJM) published positive data that expand upon previously announced long-term follow-up data for up to 3.5 years from the Phase 1/2 dose-finding B-AMAZE trial of the company’s AAVS3 gene therapy candidate, FLT180a, for people with hemophilia B.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Rod MacLeod , Nevro’s Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference.

Bristol Myers Squibb NYSE (BMY) announced the first biopharma three-year exclusive collaboration with the premier African American Family Organization, Jack and Jill of America, Inc. to inspire more Black and African American individuals to join the biopharma industry.

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that industry veteran Chris Smith has been appointed Chief Executive Officer and a member of the board of directors effective August 15, 2022.